BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 35.34 Million USD | 6.16% |
| 2022 | 33.29 Million USD | 10.71% |
| 2021 | 30.07 Million USD | -2.97% |
| 2020 | 30.99 Million USD | -1.5% |
| 2019 | 31.47 Million USD | 14.74% |
| 2018 | 27.42 Million USD | 99.85% |
| 2017 | 13.72 Million USD | -30.95% |
| 2016 | 19.87 Million USD | 14.72% |
| 2015 | 17.32 Million USD | -0.12% |
| 2014 | 17.34 Million USD | -23.1% |
| 2013 | 22.55 Million USD | 11.78% |
| 2012 | 20.17 Million USD | 17.06% |
| 2011 | 17.23 Million USD | -18.67% |
| 2010 | 21.19 Million USD | 48.75% |
| 2009 | 14.24 Million USD | -45.86% |
| 2008 | 26.31 Million USD | -5.39% |
| 2007 | 27.81 Million USD | 4.53% |
| 2006 | 26.61 Million USD | 11.65% |
| 2005 | 23.83 Million USD | -3.77% |
| 2004 | 24.76 Million USD | 94.73% |
| 2003 | 12.71 Million USD | 38.13% |
| 2002 | 9.2 Million USD | 53.93% |
| 2001 | 5.98 Million USD | 7.93% |
| 2000 | 5.54 Million USD | 53.46% |
| 1999 | 3.61 Million USD | 12.86% |
| 1998 | 3.2 Million USD | 146.15% |
| 1997 | 1.3 Million USD | 62.5% |
| 1996 | 800 Thousand USD | 14.29% |
| 1995 | 700 Thousand USD | 0.0% |
| 1994 | 700 Thousand USD | -70.83% |
| 1993 | 2.4 Million USD | -14.29% |
| 1992 | 2.8 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 36.28 Million USD | 2.66% |
| 2024 Q2 | 34.97 Million USD | -3.63% |
| 2023 Q1 | 33.78 Million USD | 1.47% |
| 2023 FY | 35.34 Million USD | 6.16% |
| 2023 Q3 | 32.86 Million USD | 1.76% |
| 2023 Q2 | 32.29 Million USD | -4.42% |
| 2023 Q4 | 35.34 Million USD | 7.57% |
| 2022 Q3 | 29 Million USD | -0.79% |
| 2022 Q4 | 33.29 Million USD | 14.79% |
| 2022 FY | 33.29 Million USD | 10.71% |
| 2022 Q1 | 29.64 Million USD | -1.44% |
| 2022 Q2 | 29.23 Million USD | -1.36% |
| 2021 Q1 | 29.96 Million USD | -3.32% |
| 2021 Q2 | 27.99 Million USD | -6.59% |
| 2021 FY | 30.07 Million USD | -2.97% |
| 2021 Q3 | 28.19 Million USD | 0.71% |
| 2021 Q4 | 30.07 Million USD | 6.68% |
| 2020 Q2 | 26.44 Million USD | -10.0% |
| 2020 FY | 30.99 Million USD | -1.5% |
| 2020 Q1 | 29.38 Million USD | -6.62% |
| 2020 Q3 | 28.14 Million USD | 6.42% |
| 2020 Q4 | 30.99 Million USD | 10.13% |
| 2019 Q1 | 26.83 Million USD | -2.15% |
| 2019 Q3 | 29.33 Million USD | 2.69% |
| 2019 Q4 | 31.47 Million USD | 7.26% |
| 2019 FY | 31.47 Million USD | 14.74% |
| 2019 Q2 | 28.57 Million USD | 6.46% |
| 2018 Q3 | 17.91 Million USD | 17.43% |
| 2018 Q1 | 15.44 Million USD | 12.55% |
| 2018 FY | 27.42 Million USD | 99.85% |
| 2018 Q4 | 27.42 Million USD | 53.06% |
| 2018 Q2 | 15.25 Million USD | -1.22% |
| 2017 Q4 | 13.72 Million USD | -15.21% |
| 2017 FY | 13.72 Million USD | -30.95% |
| 2017 Q1 | 18.67 Million USD | -6.05% |
| 2017 Q2 | 16.97 Million USD | -9.08% |
| 2017 Q3 | 16.18 Million USD | -4.67% |
| 2016 FY | 19.87 Million USD | 14.72% |
| 2016 Q4 | 19.87 Million USD | 7.1% |
| 2016 Q3 | 18.55 Million USD | 8.86% |
| 2016 Q1 | 16.82 Million USD | -2.89% |
| 2016 Q2 | 17.04 Million USD | 1.33% |
| 2015 Q2 | 20.28 Million USD | 15.5% |
| 2015 Q1 | 17.56 Million USD | 1.26% |
| 2015 Q3 | 20.8 Million USD | 2.55% |
| 2015 FY | 17.32 Million USD | -0.12% |
| 2015 Q4 | 17.32 Million USD | -16.72% |
| 2014 Q2 | 23.49 Million USD | 19.56% |
| 2014 Q4 | 17.34 Million USD | -7.74% |
| 2014 Q1 | 19.65 Million USD | -12.88% |
| 2014 FY | 17.34 Million USD | -23.1% |
| 2014 Q3 | 18.8 Million USD | -19.97% |
| 2013 Q3 | 23.35 Million USD | -3.86% |
| 2013 Q2 | 24.29 Million USD | 16.55% |
| 2013 Q1 | 20.84 Million USD | 3.31% |
| 2013 FY | 22.55 Million USD | 11.78% |
| 2013 Q4 | 22.55 Million USD | -3.43% |
| 2012 Q2 | 17.61 Million USD | 10.17% |
| 2012 Q4 | 20.17 Million USD | 9.38% |
| 2012 Q1 | 15.98 Million USD | -7.26% |
| 2012 Q3 | 18.44 Million USD | 4.75% |
| 2012 FY | 20.17 Million USD | 17.06% |
| 2011 FY | 17.23 Million USD | -18.67% |
| 2011 Q2 | 15 Million USD | -6.02% |
| 2011 Q1 | 15.96 Million USD | -24.66% |
| 2011 Q3 | 15.1 Million USD | 0.67% |
| 2011 Q4 | 17.23 Million USD | 14.11% |
| 2010 Q4 | 21.19 Million USD | -8.01% |
| 2010 FY | 21.19 Million USD | 48.75% |
| 2010 Q3 | 23.04 Million USD | 6.76% |
| 2010 Q2 | 21.58 Million USD | 27.86% |
| 2010 Q1 | 16.87 Million USD | 18.47% |
| 2009 Q1 | 17.02 Million USD | -35.31% |
| 2009 Q2 | 14.67 Million USD | -13.79% |
| 2009 Q3 | 14.11 Million USD | -3.82% |
| 2009 Q4 | 14.24 Million USD | 0.94% |
| 2009 FY | 14.24 Million USD | -45.86% |
| 2008 Q2 | 19.99 Million USD | -17.87% |
| 2008 Q1 | 24.34 Million USD | -12.47% |
| 2008 Q4 | 26.31 Million USD | -0.55% |
| 2008 Q3 | 26.46 Million USD | 32.34% |
| 2008 FY | 26.31 Million USD | -5.39% |
| 2007 Q2 | 21.95 Million USD | -8.68% |
| 2007 FY | 27.81 Million USD | 4.53% |
| 2007 Q1 | 24.03 Million USD | -9.68% |
| 2007 Q3 | 21.9 Million USD | -0.23% |
| 2007 Q4 | 27.81 Million USD | 27.02% |
| 2006 Q4 | 26.61 Million USD | 12.73% |
| 2006 Q2 | 24.77 Million USD | 2.3% |
| 2006 FY | 26.61 Million USD | 11.65% |
| 2006 Q3 | 23.6 Million USD | -4.7% |
| 2006 Q1 | 24.21 Million USD | 1.6% |
| 2005 Q1 | 20.5 Million USD | -17.2% |
| 2005 Q4 | 23.83 Million USD | 10.94% |
| 2005 FY | 23.83 Million USD | -3.77% |
| 2005 Q3 | 21.48 Million USD | 0.84% |
| 2005 Q2 | 21.3 Million USD | 3.89% |
| 2004 FY | 24.76 Million USD | 94.73% |
| 2004 Q1 | 7.6 Million USD | -40.19% |
| 2004 Q2 | 9.82 Million USD | 29.14% |
| 2004 Q3 | 11.46 Million USD | 16.72% |
| 2004 Q4 | 24.76 Million USD | 115.99% |
| 2003 FY | 12.71 Million USD | 38.13% |
| 2003 Q4 | 12.71 Million USD | 13.7% |
| 2003 Q3 | 11.18 Million USD | -14.99% |
| 2003 Q2 | 13.15 Million USD | 55.84% |
| 2003 Q1 | 8.44 Million USD | -8.3% |
| 2002 Q4 | 9.2 Million USD | 22.02% |
| 2002 Q3 | 7.54 Million USD | 9.71% |
| 2002 Q1 | 6.72 Million USD | 12.44% |
| 2002 FY | 9.2 Million USD | 53.93% |
| 2002 Q2 | 6.87 Million USD | 2.26% |
| 2001 Q2 | 4.9 Million USD | 4.79% |
| 2001 Q1 | 4.67 Million USD | -15.59% |
| 2001 Q4 | 5.98 Million USD | 13.06% |
| 2001 Q3 | 5.29 Million USD | 7.92% |
| 2001 FY | 5.98 Million USD | 7.93% |
| 2000 Q3 | 5.04 Million USD | 40.61% |
| 2000 Q1 | 3.78 Million USD | 4.75% |
| 2000 Q2 | 3.58 Million USD | -5.16% |
| 2000 Q4 | 5.54 Million USD | 9.86% |
| 2000 FY | 5.54 Million USD | 53.46% |
| 1999 Q3 | 2.9 Million USD | -3.33% |
| 1999 FY | 3.61 Million USD | 12.86% |
| 1999 Q4 | 3.61 Million USD | 24.54% |
| 1999 Q1 | 3.7 Million USD | 15.63% |
| 1999 Q2 | 3 Million USD | -18.92% |
| 1998 Q2 | 2.1 Million USD | 5.0% |
| 1998 Q1 | 2 Million USD | 53.85% |
| 1998 FY | 3.2 Million USD | 146.15% |
| 1998 Q3 | 2.4 Million USD | 14.29% |
| 1998 Q4 | 3.2 Million USD | 33.33% |
| 1997 Q1 | 900 Thousand USD | 12.5% |
| 1997 FY | 1.3 Million USD | 62.5% |
| 1997 Q2 | 700 Thousand USD | -22.22% |
| 1997 Q3 | 900 Thousand USD | 28.57% |
| 1997 Q4 | 1.3 Million USD | 44.44% |
| 1996 Q4 | 800 Thousand USD | 14.29% |
| 1996 Q3 | 700 Thousand USD | 16.67% |
| 1996 Q2 | 600 Thousand USD | 0.0% |
| 1996 FY | 800 Thousand USD | 14.29% |
| 1996 Q1 | 600 Thousand USD | -14.29% |
| 1995 Q2 | 600 Thousand USD | -25.0% |
| 1995 Q1 | 800 Thousand USD | 14.29% |
| 1995 Q3 | 600 Thousand USD | 0.0% |
| 1995 Q4 | 700 Thousand USD | 16.67% |
| 1995 FY | 700 Thousand USD | 0.0% |
| 1994 Q2 | 800 Thousand USD | 0.0% |
| 1994 Q4 | 700 Thousand USD | -22.22% |
| 1994 FY | 700 Thousand USD | -70.83% |
| 1994 Q3 | 900 Thousand USD | 12.5% |
| 1993 Q1 | 2.8 Million USD | 0.0% |
| 1993 Q2 | 3.1 Million USD | 10.71% |
| 1993 Q3 | 2.3 Million USD | -25.81% |
| 1993 FY | 2.4 Million USD | -14.29% |
| 1993 Q4 | 2.4 Million USD | 4.35% |
| 1992 Q4 | 2.8 Million USD | -9.68% |
| 1992 FY | 2.8 Million USD | 0.0% |
| 1992 Q2 | 2.9 Million USD | 0.0% |
| 1992 Q3 | 3.1 Million USD | 6.9% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 35.542% |
| Axonics, Inc. | 82.35 Million USD | 57.081% |
| INVO Bioscience, Inc. | 19.99 Million USD | -76.785% |
| CVRx, Inc. | 39.28 Million USD | 10.015% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 84.152% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1010.894% |
| MaxCyte, Inc. | 36.1 Million USD | 2.102% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -64.501% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 71.485% |
| Sintx Technologies, Inc. | 6.59 Million USD | -436.144% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 31.034% |
| Apyx Medical Corporation | 52.31 Million USD | 32.436% |
| Cutera, Inc. | 518.12 Million USD | 93.178% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -561.7% |
| NeuroPace, Inc. | 86.99 Million USD | 59.369% |
| IRIDEX Corporation | 24.91 Million USD | -41.88% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 59.738% |
| enVVeno Medical Corporation | 2.43 Million USD | -1351.663% |
| TELA Bio, Inc. | 59.16 Million USD | 40.257% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 94.468% |
| UFP Technologies, Inc. | 118.04 Million USD | 70.055% |
| Modular Medical, Inc. | 2.27 Million USD | -1455.81% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -20.526% |
| LENSAR, Inc. | 22.4 Million USD | -57.74% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.389% |
| Surmodics, Inc. | 65.82 Million USD | 46.298% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -242.553% |
| Inogen, Inc. | 121.38 Million USD | 70.879% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -2011.589% |
| RxSight, Inc. | 22.18 Million USD | -59.311% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -8211.681% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -19.496% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -52.797% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -8211.681% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -1355.069% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 66.208% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 94.975% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -38.821% |
| Dynatronics Corporation | 11.78 Million USD | -200.065% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 31.58% |
| InMode Ltd. | 75.91 Million USD | 53.437% |
| Bruker Corporation | 2.83 Billion USD | 98.754% |
| Movano Inc. | 5.97 Million USD | -491.896% |
| Orthofix Medical Inc. | 326.58 Million USD | 89.176% |
| FONAR Corporation | 57.45 Million USD | 38.48% |
| BioSig Technologies, Inc. | 4.68 Million USD | -654.493% |
| Envoy Medical, Inc. | 9.4 Million USD | -275.963% |
| Align Technology, Inc. | 2.45 Billion USD | 98.559% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 39.438% |
| Talis Biomedical Corporation | 29.22 Million USD | -20.955% |
| Cerus Corporation | 144.3 Million USD | 75.504% |
| 908 Devices Inc. | 37.49 Million USD | 5.714% |
| Nemaura Medical Inc. | 26.37 Million USD | -34.009% |
| Outset Medical, Inc. | 190.91 Million USD | 81.485% |
| NanoVibronix, Inc. | 2.68 Million USD | -1216.009% |
| Venus Concept Inc. | 107.1 Million USD | 66.996% |
| Telesis Bio, Inc. | 40.87 Million USD | 13.517% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 68.985% |
| Quipt Home Medical Corp. | 136.29 Million USD | 74.065% |
| IRadimed Corporation | 20.73 Million USD | -70.467% |
| Tenon Medical, Inc. | 5.56 Million USD | -534.956% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -889.586% |
| Pulmonx Corporation | 60.63 Million USD | 41.705% |
| iCAD, Inc. | 8 Million USD | -341.795% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -178.539% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1812.864% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 13.342% |
| SI-BONE, Inc. | 61.05 Million USD | 42.1% |
| Semler Scientific, Inc. | 6.27 Million USD | -463.764% |
| Biotricity, Inc. | 35.91 Million USD | 1.591% |
| Cytosorbents Corporation | 29.98 Million USD | -17.884% |
| DexCom, Inc. | 4.19 Billion USD | 99.158% |
| ZimVie Inc. | 795.85 Million USD | 95.558% |
| Aethlon Medical, Inc. | 2.47 Million USD | -1325.524% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -195.599% |
| IceCure Medical Ltd | 4.24 Million USD | -732.305% |
| PAVmed Inc | 57.13 Million USD | 38.135% |
| Sight Sciences, Inc. | 46.43 Million USD | 23.878% |
| Insulet Corporation | 1.85 Billion USD | 98.095% |
| Profound Medical Corp. | 12.66 Million USD | -179.081% |
| electroCore, Inc. | 8.94 Million USD | -295.17% |
| Bioventus Inc. | 589.79 Million USD | 94.007% |
| InspireMD, Inc. | 8.14 Million USD | -334.144% |
| PAVmed Inc. | 57.13 Million USD | 38.135% |
| Nuwellis, Inc. | 6.78 Million USD | -421.357% |
| OrthoPediatrics Corp. | 72.56 Million USD | 51.285% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -195.599% |
| BrainsWay Ltd. | 15.31 Million USD | -130.821% |
| Beyond Air, Inc. | 29.77 Million USD | -18.717% |
| AxoGen, Inc. | 101.16 Million USD | 65.058% |
| Inari Medical, Inc. | 209.32 Million USD | 83.113% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1517.156% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1886.959% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.879% |
| Quanterix Corporation | 78.08 Million USD | 54.731% |
| Viveve Medical, Inc. | 10.84 Million USD | -225.878% |
| LivaNova PLC | 1.15 Billion USD | 96.931% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -100.452% |
| Varex Imaging Corporation | 668.6 Million USD | 94.713% |
| Vivani Medical, Inc. | 25.03 Million USD | -41.189% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -769.783% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -889.586% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -623.603% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 96.616% |
| TransMedics Group, Inc. | 568.84 Million USD | 93.786% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -111.893% |
| NeuroMetrix, Inc. | 1.33 Million USD | -2551.516% |
| Spectral AI, Inc. | 12.4 Million USD | -185.042% |
| Hyperfine, Inc. | 9.8 Million USD | -260.694% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 85.875% |
| Biomerica, Inc. | 2.66 Million USD | -1227.375% |
| Bone Biologics Corporation | 831.4 Thousand USD | -4151.614% |
| AVITA Medical, Inc. | 19.86 Million USD | -77.937% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1690.966% |
| Silk Road Medical, Inc | 114.15 Million USD | 69.036% |